About
Research
Products
Investors
Careers
Agenda
fr
Corporate Presentations
stock information
press releases
events and webcasts
corporate presentations
Financial Statements
SEC filings
Regulated information
General meetings
Governance
The board and committee members
Corporate governance documents
FAQ
Our Corporate Presentations
All
2019
2018
2017
2016
2015
2014
06
Jun 2019
17:31 E.S.T.
Corporate Presentation June 2019
Download the PDF file
21
May 2019
16:30 E.S.T.
2018 Annual Report
Download the PDF file
26
Jun 2018
16:30 E.S.T.
Development of allogeneic gene-edited CAR T cells: from preclinic to clinical proof of concept
Download the PDF file
21
Jun 2018
16:30 E.S.T.
2017 Annual Report
Download the PDF file
18
Jun 2018
08:00 E.S.T.
EHA Posters 2018
Download the PDF file
20
May 2018
08:24 E.S.T.
ASGCT Posters 2018
Download the PDF file
18
Apr 2018
16:00 E.S.T.
AACR Posters 2018
Download the PDF file
13
Dec 2017
17:10 E.S.T.
ASH 2017 - Preliminary results of UCART19, an allogeneic anti-CD19 CAR Tcell product, in a first-in-human trial (CALM) in adult patients with CD19+ relapsed/refractory B-cell acute lymphoblastic leukemia
Download the PDF file
13
Dec 2017
17:07 E.S.T.
ASH 2017 - Preliminary Results of UCART19, an Allogeneic Anti-CD19 CAR T-Cell Product in a First-in-Human Trial (PALL) in Pediatric Patients with CD19+ Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia
Download the PDF file
13
Dec 2017
16:59 E.S.T.
ASH 2017 - Pre-clinical Studies of Allogeneic Anti-CD123 CAR-T Cells for the Treatment of Blastic plasmacytoid dendritic cell neoplasm (BPDCN)
Download the PDF file
1
2
3
Next